ATG5 and neoplasm: Additionally, administration of the autophagy inhibitor 3-methyladenine (3-MA) led to increased MTOR expression and downregulation of ATG5, ATG7, and BECN1, resulting in reduced tumor volume and elevated apoptosis cell death.